ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
SANUWAVE Health Inc (QB)

SANUWAVE Health Inc (QB) (SNWV)

0.0195
-0.001
(-4.88%)
Closed April 30 4:00PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.0195
Bid
0.0185
Ask
0.0229
Volume
179,847
0.0195 Day's Range 0.021
0.0046 52 Week Range 0.0298
Market Cap
Previous Close
0.0205
Open
0.0195
Last Trade
75000
@
0.0195
Last Trade Time
Financial Volume
$ 3,543
VWAP
0.019698
Average Volume (3m)
344,089
Shares Outstanding
1,026,078,464
Dividend Yield
-
PE Ratio
-0.79
Earnings Per Share (EPS)
-0.03
Revenue
20.4M
Net Profit
-25.81M

About SANUWAVE Health Inc (QB)

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
Headquarters
Carson City, Nevada, USA
Founded
1970
SANUWAVE Health Inc (QB) is listed in the Surgical,med Instr,apparatus sector of the OTCMarkets with ticker SNWV. The last closing price for SANUWAVE Health (QB) was $0.02. Over the last year, SANUWAVE Health (QB) shares have traded in a share price range of $ 0.0046 to $ 0.0298.

SANUWAVE Health (QB) currently has 1,026,078,464 shares outstanding. The market capitalization of SANUWAVE Health (QB) is $20.52 million. SANUWAVE Health (QB) has a price to earnings ratio (PE ratio) of -0.79.

SNWV Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0064-24.71042471040.02590.02590.01142889380.02171461CS
4-0.0015-7.142857142860.0210.02980.01142833890.0209072CS
12-0.0035-15.21739130430.0230.02980.01143440890.02173209CS
260.00168.938547486030.01790.02980.00465584260.01536364CS
52-0.0055-220.0250.02980.00464271560.01649699CS
156-0.1479-88.35125448030.16740.220.00013464890.0615066CS
260-0.1655-89.45945945950.1850.3190.00013297240.11347805CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CSLRComplete Solaria Inc
$ 0.7303
(91.73%)
25.8M
MULNMullen Automotive Inc
$ 5.73
(81.33%)
72.12M
DCPHDeciphera Pharmaceuticals Inc
$ 25.28
(72.56%)
50.72M
CAUDCollective Audience Inc
$ 0.6377
(63.51%)
157.73M
LICNLichen China Limited
$ 2.03
(48.18%)
3.96M
CLVRClever Leaves Holdings Inc
$ 1.62
(-60.58%)
768.37k
ADXNAddex Therapeutics Ltd
$ 7.68
(-52.30%)
160.84k
TSDDGraniteShares ETF Trust GraniteShares
$ 17.1879
(-30.97%)
1.64M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
$ 27.23
(-30.66%)
7.72M
MFImF International Ltd
$ 1.665
(-28.54%)
3.55M
TSLATesla Inc
$ 194.05
(15.31%)
243.77M
SINTSiNtx Technologies Inc
$ 0.053477
(32.37%)
174.36M
CAUDCollective Audience Inc
$ 0.6377
(63.51%)
157.73M
SOFISoFi Technologies Inc
$ 7.045
(-10.48%)
149.63M
SQQQProShares UltraPro Short QQQ
$ 11.31
(-1.05%)
97.67M

SNWV Discussion

View Posts
janeyH janeyH 2 months ago
On March 6, 2024, Sanuwave, Inc. entered into an exclusive license and option agreement (the โ€œLicense and Option Agreementโ€) with a third party licensee (the โ€œLicenseeโ€) in connection with a portfolio of Sanuwave, Inc. patents related to the field of intravascular shockwave applications (the โ€œPatentsโ€). In exchange for a one-time payment of $2.5 million, Sanuwave, Inc. granted the Licensee an exclusive license to the Patents and an option to acquire the Patents for an additional one-time payment in the single-digit millions of dollars (the โ€œLicense and Option Transactionโ€). If the Licensee does not exercise its option to acquire the Patents during a specified option period, the license terminates and all rights revert back to Sanuwave, Inc.
๐Ÿ‘๏ธ0
janeyH janeyH 2 months ago
* SEP ACQUISITION CORP (SEPA) - PURSUANT TO AMENDMENT, "OUTSIDE DATE" UNDER MERGER AGREEMENT HAS BEEN EXTENDED TO APRIL 30, 2024
๐Ÿ‘๏ธ0
janeyH janeyH 2 months ago
I am the only person in the world that has purchased the stock today. Yay me.
๐Ÿ‘๏ธ0
janeyH janeyH 2 months ago
janey not wrong - rest of world not right
๐Ÿ‘๏ธ0
janeyH janeyH 2 months ago
got over that hurdle ... should be full-on heading toward the close of the transaction ...
๐Ÿ‘๏ธ0
janeyH janeyH 2 months ago
janey says: we will be over 3 for good by the end of the week
๐Ÿ‘๏ธ0
janeyH janeyH 2 months ago
i've got some of each as well
๐Ÿ‘๏ธ0
MikeyInTheD MikeyInTheD 2 months ago
Splitting my position between the two to play any extra upside one or the other may have in the end. Completely under the radar transaction and promising revenue stream for a well funded entity following the combination. Easy money to be had at these levels.
๐Ÿ‘๏ธ0
janeyH janeyH 2 months ago
are you playing the SEPA side at all?
๐Ÿ‘๏ธ0
janeyH janeyH 2 months ago
That would be a nice 5X or 6X from here
๐Ÿ‘๏ธ0
MikeyInTheD MikeyInTheD 2 months ago
This is a 0.15 stock on the slightest hint of positive news. Iโ€™m loading at these levels now that weโ€™ve bounced off the bottom. A big jump is coming given the consolidation in the 0.025 range
๐Ÿ‘๏ธ0
janeyH janeyH 2 months ago
big day coming up tomorrow - shareholder vote on the SPAC
๐Ÿ‘๏ธ0
janeyH janeyH 3 months ago
Sanuwave Announces Special Meeting of Stockholders to Vote on Business Combination with SEP Acquisition Corp. (Nasdaq: SEPA)

EDEN PRAIRIE, MN, January 22, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sanuwave Health, Inc. (the "Company" or "Sanuwaveโ€) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today announced the Company is holding a special meeting of stockholders on February 21, 2024 at 10:00 a.m. CT (11:00 a.m. ET) to vote on the previously announced merger with SEP Acquisition Corp (โ€œSEPAโ€).

Sanuwave announced on August 23, 2023 that the Company entered into an Agreement and Plan of Merger with Sweat Equity Partners and Mercury Life Sciences-affiliated SEPA. Upon closing, the combined company is expected to trade on the Nasdaq Capital Market under the symbol โ€œSNWVโ€.

The Company has commenced mailing proxy materials to stockholders to vote on proposals related to the merger with SEPA. Stockholders of record at the close of business on January 10, 2023 will be entitled to vote at the special meeting.

The Companyโ€™s board of directors unanimously recommends that stockholders vote โ€œFORโ€ the merger proposal.

โ€œSpeaking for the Company and its board of directors, weโ€™re all extremely excited about this transaction and see it as the freeing move to put the company upon a sound financial footing, simplify the capital structure, and to move up to the Nasdaq Capital Markets, said Sanuwave CEO Morgan Frank. โ€œThis will allow us to focus on rapid, profitable growth and to garner an equity valuation that reflects the performance of our business. My deep thanks to the Sanuwave team and all those who have helped us get here.โ€
๐Ÿ‘๏ธ0
DrZSmith DrZSmith 3 months ago
"A leading provider of next-generation FDA-approved wound care products."
"UltraMist revenues accounted for approximately 95% of the companyโ€™s total revenue."

I'm sorry, but after 5+ years in the wound care space two things remain clear.
1, Despite millions spent in the push of the DP product, and having that as sole #1 focus, the back burner (10+ year old techno) product is the only bullet in the gun.
2. Calling SNWV a leader of next-generation WC products is akin to calling the Big Mac nutritious.
👍️ 1
janeyH janeyH 4 months ago
EDEN PRAIRIE, MN, Jan. 10, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire โ€“ SANUWAVE Health, Inc. (SNWV) (the "Company" or "SANUWAVEโ€) , a leading provider of next-generation FDA-approved wound care products, today announced that revenues for the fourth quarter of 2023 are expected to be in the range of $6.6 to $6.8 million, an increase of 20% to 24% over Q4 2022. Fiscal year 2023 revenues are expected to be in the range of $20.0 million to $20.2 million, an increase of 19% to 20% over the fiscal year ended 2022.

โ€œQ4 2023 was a record quarter of revenue for SANUWAVE driven by strength in the UltraMist product line. Consumables and in particular system sales saw accelerating growth as production constraints were overcome,โ€ said CEO Morgan Frank. โ€œWeโ€™re extremely pleased to have shown this level of growth year on year up against what had previously been the best quarter in SANUWAVE history in Q4 2022 and look forward to carrying this success on into 2024. The Company plans to release its full Q4 and annual results in late March and we look forward to speaking with you then to give you a more complete update on our quarterly and yearly performance and our future plans and guidance.โ€

The preliminary revenue results described herein are based on managementโ€™s initial analysis of the fourth quarter ended December 31, 2023, and may be subject to adjustments based on the Companyโ€™s completion of its year-end financial close process.
๐Ÿ‘๏ธ0
janeyH janeyH 4 months ago
ยท The transaction is expected to close in the fourth quarter of 2023, subject to the satisfaction of the agreed upon closing conditions.

Hmph - soon ... ?
๐Ÿ‘๏ธ0
janeyH janeyH 4 months ago
DrZ? Still lurking? Nice way tp start year - musta been some heavy tax selling keeping it down.
๐Ÿ‘๏ธ0
janeyH janeyH 4 months ago
somebody dum[ping this shit hard - SPAC called off?????????
๐Ÿ‘๏ธ0
janeyH janeyH 5 months ago
Almost 1mm shares in a Green Day โ€ฆ whuuuuuut!!
๐Ÿ‘๏ธ0
janeyH janeyH 5 months ago
lottsa dumpin goin on
๐Ÿ‘๏ธ0
janeyH janeyH 5 months ago
5m share day
๐Ÿ‘๏ธ0
janeyH janeyH 5 months ago
All good Q, Z.

Looks like a binary outcome here: SPAC happens, they get to NASDAQ and its rainbows and lucky charms OR spac doesnt happen and it goes down the shittter.

What are you betting on?
๐Ÿ‘๏ธ0
janeyH janeyH 5 months ago
https://www.investopedia.com/ask/answers/011315/what-difference-between-authorized-shares-and-outstanding-shares.asp#

Authorized shares are the maximum number of shares a company is allowed to issue to investors as laid out in its articles of incorporation.

Outstanding shares are the actual shares issued or sold to investors from the available number of authorized shares.
๐Ÿ‘๏ธ0
janeyH janeyH 6 months ago
Friday 8 AM EST conference call feels like they're trying to squeak out some bad Q3 numbers - at that rate just do it 5 PM PST on frday!
๐Ÿ‘๏ธ0
janeyH janeyH 6 months ago
the smart money is already in at this level
๐Ÿ‘๏ธ0
janeyH janeyH 6 months ago
doin' a little bottom feeding ... SPAC and uplist should happen in the next 60 days
๐Ÿ‘๏ธ0
kellyemmerson kellyemmerson 6 months ago
There are approximately 3.0 Billion shares outstanding not including the $25.0 milliion to Morgan Stanley
So, at $.02/share the current market cap is $60.0 million.
You add in the $25.0 million of debt and that comes to $85.0 milllion
The valuation seems fair.....haven't done a deep dive on how much we (sanuwave will have after the merger. I'm assuming the spac sponsors will retain 20%
So, yeah...these numbers seem right
👍️ 1
janeyH janeyH 7 months ago
how can this possibly be true:

"Sanuwave is being valued at a total enterprise value of $125 million in the transaction and holders of Sanuwave common stock will upon consummation of the merger receive shares of SEPA Class A common stock in exchange for their existing holdings. "

When the co is valued at Market cap. Micro Cap ($19.34M) by the share price. Something is def fishy here.
👍️ 1 😵 1
janeyH janeyH 7 months ago
Am i being naive ...

- douche bag CEO gone
- SPAC uplist to NASDAQ
- new board, new mgmt
- an articulable strategy (like it or not like it)

Assuming SPAC has done it's homework, it looks like there is value here.
๐Ÿ‘๏ธ0
kellyemmerson kellyemmerson 7 months ago
New presentation filed with the SEC yesterday. More info to come with the S4 as well.
๐Ÿ‘๏ธ0
janeyH janeyH 7 months ago
what is going to happen with this coming acquisition?
๐Ÿ‘๏ธ0
DrZSmith DrZSmith 8 months ago
I see where 3 of SNWV's primary and former RMs filed joint legal action against them in July. Noticed the new group also made zero mention of the main focus and driving force behind SNWV. Have they finally walked away from that non-producing DP? Are they going to rely on tired worn technology as the driver? Technology that they have admitted to not having an inventory of since 10/21.
👍️ 1
thumper1 thumper1 8 months ago
dr z smith....so whats your opinion on the latest news...
the merger...
looking forward to what you have to say,

best to you
๐Ÿ‘๏ธ0
kellyemmerson kellyemmerson 9 months ago
You mean 2.0 BILLION shares. You didn't account for the warrants last time either.
๐Ÿ‘๏ธ0
janeyH janeyH 9 months ago
All that and 1,000,000,000 shares OS
๐Ÿ‘๏ธ0
DrZSmith DrZSmith 9 months ago
Since approval, DP had never had legitimate momentum in the wound care space. The financials/sales validate that fact. Without competitive reimbursement and a solid business plan (which has never been present), it's impossible to obtain traction and be competitive. Moreover, there are multiple like players in this tech space with much better leadership, direction, and pricing. On the flip, Mist is old technology, breaks down easily, and no company has produced a new unit since Alliqua.

The bottom line is the low single is where SNWV stock will live until sold off.
๐Ÿ‘๏ธ0
janeyH janeyH 9 months ago
And derma pace all but shelved.

95% revenues for foreseeable future from Mist
๐Ÿ‘๏ธ0
DrZSmith DrZSmith 9 months ago
To sell what? They could have 2,000 reps and it makes no difference. You can't sell products or systems you don't have. Besides Pacific is not in the wound care business.
๐Ÿ‘๏ธ0
janeyH janeyH 9 months ago
i WAS counting it correctly, SNWV mgmt is just selling shares like 1950s candy - a penny a piece
๐Ÿ‘๏ธ0
kellyemmerson kellyemmerson 9 months ago
I told you that you weren't counting it correctly.
With that being said, you aren't including the warrants which brings it to 2.0 BILLION SHARES now
๐Ÿ‘๏ธ0
janeyH janeyH 9 months ago
Market cap.Micro Cap ($20.52M)
Shares outstanding1,026,078,464

DOUBLED!!!!!!!!!! since June 30
👍️ 1
thumper1 thumper1 9 months ago
pacific...215 reps...very good eom
๐Ÿ‘๏ธ0
thumper1 thumper1 9 months ago
very good news.....imo, they're getting serious...
should of done this long ago...but thats ok...
will do my dd on pacific....best to all
๐Ÿ‘๏ธ0
AJ Freely AJ Freely 9 months ago
$SNWV - Signs Distribution Agreement With Pacific Medical, Inc.
👉Current Price $0.017
๐Ÿ‘๏ธ0
janeyH janeyH 9 months ago
Morgan C. Frank
Interim Chief Executive Officer
SANUWAVE Health, Inc.
11495 Valley View Road
Eden Prairie, Minnesota 55344
(770) 419-7525
๐Ÿ‘๏ธ0
janeyH janeyH 10 months ago
When is the next CEO coming in?
👍️ 1
janeyH janeyH 11 months ago
https://www.linkedin.com/in/morgan-frank-b6a235/details/experience/
๐Ÿ‘๏ธ0
janeyH janeyH 11 months ago
Just a dump fest
๐Ÿ‘๏ธ0
janeyH janeyH 11 months ago
Market cap. Micro Cap ($7.68M)
Shares outstanding 548,737,651
๐Ÿ‘๏ธ0
janeyH janeyH 11 months ago
but somehow i feel like it would be selling at the bottom

nope it goes even fucking lower
๐Ÿ‘๏ธ0

Your Recent History

Delayed Upgrade Clock